A. J. Kazimi - 16 Mar 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
16 Mar 2022
Net transactions value
-$50,142
Form type
4
Filing time
29 Apr 2022, 12:58:09 UTC
Previous filing
07 Jan 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $51,800 +20,000 +0.35% $2.59 5,790,563 16 Mar 2022 Direct F1
transaction CPIX Common Stock Tax liability $101,942 -37,205 -0.64% $2.74 5,753,358 20 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Award $0 +80,000 $0.000000 80,000 16 Mar 2022 Common Stock 80,000 $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 16, 2026.
F2 This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.